Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions

American Journal of Cardiology

Volumn 107, Issue 12, 2011, Pages 1768-1771

  Valenti, Renato ^a   Vergara, Ruben ^a   Migliorini, Angela ^a   Parodi, Guido ^a   Buonamici, Piergiovanni ^a   Cerisano, Giampaolo ^a   Carrabba, Nazario ^a   Antoniucci, David ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL;

AGED; ANGIOCARDIOGRAPHY; CHRONIC TOTAL OCCLUSION; CONFERENCE PAPER; DRUG EFFICACY; DRUG ELUTING STENT; DRUG FATALITY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RISK REDUCTION;

AGED; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PACLITAXEL; SIROLIMUS; TREATMENT OUTCOME;

EID: 79957965956     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.01.063     Document Type: Conference Paper

References (13)

1. P.W. Serruys, P.N. Ruygrok, J. Neuzner, J.J. Piek, A. Seth, J.J. Schofer, G. Richardt, M. Wiemer, D. Carri, L. Thuesen, E. Boone, K. Miquel-Herbert, and J. Daemen A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
2. G.W. Stone, M. Midei, W. Newman, M. Sanz, J.B. Hermiller, J. Williams, N. Farhat, R. Caputo, N. Xenopoulos, R. Applegate, P. Gordon, R.M. White, K. Sudhir, D.E. Cutlip, J.L. Petersen Spirit III Investigators Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial Circulation 119 2009 680 686
3. G.W. Stone, A. Rizvi, W. Newman, K. Mastali, J.C. Wang, R. Caputo, J. Doostzadeh, S. Cao, C.A. Simonton, K. Sudhir, A.J. Lansky, D.E. Cutlip, D.J. Kereiakes Spirit IV Investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
4. E. Kedhi, K.S. Joesoef, E. McFadden, J. Wassing, C. van Mieghem, D. Goedhart, and P.C. Smits Second generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
5. R. Valenti, A. Migliorini, U. Signorini, R. Vergara, G. Parodi, N. Carrabba, G. Cerisano, and D. Antoniucci Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion Eur Heart J 29 2008 2336 2342
6. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
7. A. Qasim, J. Cosgrave, A. Latib, and A. Colombo Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications Am J Cardiol 100 2007 1619 1624 (Pubitemid 350122326)
8. P. Roy, A.N. Buch, A. Javaid, T. Okabe, V. Raya, T.L. Pinto Slottow, D.H. Steinberg, K. Smith, Z. Xue, N. Gevorkian, L.F. Satler, K.M. Kent, W.O. Suddath, A.D. Pichard, J. Lindsay, and R. Waksman Impact of "off- label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention Am J Cardiol 101 2008 293 299 (Pubitemid 351162956)
9. O.C. Marroquin, F. Selzer, S.R. Mulukutla, D.O. Williams, H.A. Vlachos, R.L. Wilensky, J.F. Tanguay, E.M. Holper, J.D. Abbott, J.S. Lee, C. Smith, W.D. Anderson, S.F. Kelsey, and K.E. Kip A comparison of bare-metal and drug-eluting stents for off-label indications N Engl J Med 358 2008 342 352 (Pubitemid 351159233)
10. N. Beohar, C.J. Davidson, K.E. Kip, L. Goodreau, H.A. Vlachos, S.N. Meyers, K.H. Benzuly, J.D. Flaherty, M.J. Ricciardi, C.L. Bennett, and D.O. Williams Outcomes and complications associated with off-label and untested use of drug-eluting stents JAMA 297 2007 1992 2000 (Pubitemid 46740351)
11. C.L. Grines Off-label use of drug-eluting stents putting it in perspective J Am Coll Cardiol 51 2008 615 617
12. H.K. Win, A.E. Caldera, K. Maresh, J. Lopez, C.S. Rihal, M.A. Parikh, J.F. Granada, S. Marulkar, D. Nassif, D.J. Cohen, N.S. Kleiman EVENT Registry Investigators Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2007 2001 2009 (Pubitemid 46740352)
13. A. Farb, and A.B. Boam Stent thrombosis reduxthe FDA perspective N Engl J Med 356 2007 984 987 (Pubitemid 46376798)